-
1
-
-
67649631811
-
Serum C-reactive protein and risk of cardiovascular events in middle-aged and older Chinese population
-
Jiang S, Bao Y, Hou X, et al. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older Chinese population. Am J Cardiol. 2009 ; 103 (12). 1727-1731
-
(2009)
Am J Cardiol
, vol.103
, Issue.12
, pp. 1727-1731
-
-
Jiang, S.1
Bao, Y.2
Hou, X.3
-
2
-
-
84863275095
-
Inflammatory biomarkers in stable atherosclerosis
-
Kinlay S, Egido J. Inflammatory biomarkers in stable atherosclerosis. Am J Cardiol. 2003 ; 26 (11). 3160-3167
-
(2003)
Am J Cardiol
, vol.26
, Issue.11
, pp. 3160-3167
-
-
Kinlay, S.1
Egido, J.2
-
3
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 ; 359 (21). 2195-2207
-
(2008)
N Engl J Med
, vol.359
, Issue.21
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
-
4
-
-
0036400599
-
High sensitivity C-reactive protein: An emerging role in cardiovascular risk assessment
-
DOI 10.1080/10408360290795556
-
Benzaquen LR, Yu H, Rifai N.. High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci. 2002 ; 39 (4-5). 459-497 (Pubitemid 35176969)
-
(2002)
Critical Reviews in Clinical Laboratory Sciences
, vol.39
, Issue.4-5
, pp. 459-497
-
-
Benzaquen, L.R.1
Yu, H.2
Rifai, N.3
-
5
-
-
0035148488
-
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
-
Rifai N, Ridker PM.. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem. 2001 ; 47 (1). 28-30
-
(2001)
Clin Chem
, vol.47
, Issue.1
, pp. 28-30
-
-
Rifai, N.1
Ridker, P.M.2
-
7
-
-
70349742564
-
C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analyses for the U.S. Preventive Services Task Force
-
Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 ; 151 (7). 483-495
-
(2009)
Ann Intern Med
, vol.151
, Issue.7
, pp. 483-495
-
-
Buckley, D.I.1
Fu, R.2
Freeman, M.3
-
8
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
DOI 10.1056/NEJMoa021993
-
Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 ; 347 (20). 1557-1565 (Pubitemid 35315836)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.20
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
Buring, J.E.4
Cook, N.R.5
-
9
-
-
67349274128
-
Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease
-
Arroyo-Espliguero R, Avanzas P, Quiles J, et al. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis. 2009 ; 204 (1). 239-243
-
(2009)
Atherosclerosis
, vol.204
, Issue.1
, pp. 239-243
-
-
Arroyo-Espliguero, R.1
Avanzas, P.2
Quiles, J.3
-
10
-
-
33745190255
-
Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease
-
DOI 10.1620/tjem.209.197
-
Memon L, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, et al. Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease. Tohoku J Exp Med. 2006 ; 209 (3). 197-206 (Pubitemid 43905551)
-
(2006)
Tohoku Journal of Experimental Medicine
, vol.209
, Issue.3
, pp. 197-206
-
-
Memon, L.1
Spasojevic-Kalimanovska, V.2
Bogavac-Stanojevic, N.3
Kalimanovska-Ostric, D.4
Jelic-Ivanovic, Z.5
Spasic, S.6
Topic, A.7
-
11
-
-
10044274468
-
Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease
-
DOI 10.1016/j.atherosclerosis.2004.08.012, PII S0021915004004277
-
Taniguchi H, Momiyama Y, Ohmori R, et al. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis. 2005 ; 178 (1). 173-177 (Pubitemid 39600830)
-
(2005)
Atherosclerosis
, vol.178
, Issue.1
, pp. 173-177
-
-
Taniguchi, H.1
Momiyama, Y.2
Ohmori, R.3
Yonemura, A.4
Yamashita, T.5
Tamai, S.6
Nakamura, H.7
Ohsuzu, F.8
-
12
-
-
0035897696
-
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 ; 285 (19). 2486-2497
-
(2001)
JAMA
, vol.285
, Issue.19
, pp. 2486-2497
-
-
-
13
-
-
0037469232
-
Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
-
DOI 10.1161/01.CIR.0000052939.59093.45
-
Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003 ; 107 (3). 499-511 (Pubitemid 36158056)
-
(2003)
Circulation
, vol.107
, Issue.3
, pp. 499-511
-
-
Pearson, T.A.1
Mensah, G.A.2
Alexander, R.W.3
Anderson, J.L.4
Cannon III, R.O.5
Criqui, M.6
Fadl, Y.Y.7
Fortmann, S.P.8
Hong, Y.9
Myers, G.L.10
Rifai, N.11
Smith Jr., S.C.12
Taubert, K.13
Tracy, R.P.14
Vinicor, F.15
-
14
-
-
0038460302
-
The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report
-
DOI 10.1001/jama.289.19.2560
-
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, And Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 ; 289 (19). 2560-2572 (Pubitemid 37430158)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.19
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
15
-
-
0242300698
-
Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus
-
Genuth S, Alberti KG.. Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003 ; 26: 3160-3167
-
(2003)
Diabetes Care
, vol.26
, pp. 3160-3167
-
-
Genuth, S.1
Alberti, K.G.2
-
16
-
-
1342331006
-
2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
-
DOI 10.1161/01.CIR.0000116763.91992.F1
-
Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2004 ; 109 (7). 837-842 (Pubitemid 38252734)
-
(2004)
Circulation
, vol.109
, Issue.7
, pp. 837-842
-
-
Ballantyne, C.M.1
Hoogeveen, R.C.2
Bang, H.3
Coresh, J.4
Folsom, A.R.5
Heiss, G.6
Sharrett, A.R.7
-
17
-
-
65149100297
-
The editor's roundtable: The JUPITER trial-initial results and clinical implications
-
Ridker PM, Friedewald VE, Davidson MH, et al. The editor's roundtable: the JUPITER trial-initial results and clinical implications. Am J Cardiol. 2009 ; 103 (10). 1417-1425
-
(2009)
Am J Cardiol
, vol.103
, Issue.10
, pp. 1417-1425
-
-
Ridker, P.M.1
Friedewald, V.E.2
Davidson, M.H.3
-
18
-
-
11144355354
-
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
-
DOI 10.1056/NEJMoa040583
-
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 ; 350 (15). 1495-1504 (Pubitemid 38477774)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.15
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
Joyal, S.V.7
Hill, K.A.8
Pfeffer, M.A.9
Skene, A.M.10
-
19
-
-
33748064338
-
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial
-
DOI 10.1161/CIRCULATIONAHA.106.628909, PII 0000301720060725000007
-
Morrow DA, de Lemos JA, Sabatine MS, et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation. 2006 ; 114 (4). 281-288 (Pubitemid 44297094)
-
(2006)
Circulation
, vol.114
, Issue.4
, pp. 281-288
-
-
Morrow, D.A.1
De Lemos, J.A.2
Sabatine, M.S.3
Wiviott, S.D.4
Blazing, M.A.5
Shui, A.6
Rifai, N.7
Califf, R.M.8
Braunwald, E.9
-
20
-
-
0037126043
-
Simvastatin lowers C-reactive protein within 14 days: An effect independent of low-density lipoprotein cholesterol reduction
-
Plenge JK, Hernandez TL, Weil KM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation. 2002 ; 106 (12). 1447-1452
-
(2002)
Circulation
, vol.106
, Issue.12
, pp. 1447-1452
-
-
Plenge, J.K.1
Hernandez, T.L.2
Weil, K.M.3
|